SEC 13F Intelligence

Managers / Q2 2023 · view latest →

Cohen & Co Financial Management, LLC

CIK 0001778536 · 3 COLUMBUS CIRCLE, 24TH FLOOR, NEW YORK, NY, 10019 · 646-965-8215

Reported Value
$24M
Q2 2023
Positions
7
Filings on Record
10
2021–present window
Filed
Aug 14, 2023
original filing

Summary

Cohen & Co Financial Management, LLC reported $24M in U.S.-listed holdings across 7 positions for Q2 2023.

The portfolio is heavily concentrated: Lanzatech Global alone accounts for 88.7% of reported value.

Compared with Q1 2023, the fund opened 0 new positions and exited 2.

Portfolio Metrics

Turnover
+30.3%
vs prior filed quarter
Largest Position
+88.7%
Lanzatech Global

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q2 ’21: $157MQ2 ’21Q3 ’21: $238MQ4 ’21: $151MQ4 ’21Q1 ’22: $14MQ2 ’22: $101MQ2 ’22Q3 ’22: $58MQ4 ’22: $58MQ4 ’22Q1 ’23: $34MQ2 ’23: $24MQ2 ’23Q3 ’23: $18Mfilingsflow.com

Portfolio Composition

By security type
Other: 92.7%Equity WRT: 5.7%Common Stock: 1.6%
  • Other · 92.7% · $22M
  • Equity WRT · 5.7% · $1M
  • Common Stock · 1.6% · $389,781

Quarter-over-Quarter Changes full breakdown →

vs Q1 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
GOLDEN FALCON ACQUISITION COSOLD OUT500.0K0$5M$0
SEASTAR MEDICAL HOLDING CORPSOLD OUT623.4K0$1M$0
SFRTAPPRECIATE HOLDINGS INCTRIMMED3.06M10.0K$2M$3,602
OCEAOCEAN BIOMEDICAL INCTRIMMED1.45M64.3K$10M$386,179
LANZATECH GLOBAL INCHELD86.6K2.90M+$8M$20M
SATIXFY COMMUNICATIONS LTDHELD+02.84M$727,400$1M
LANZATECH GLOBAL INCHELD+02.01M+$522,600$1M
RUBICON TECHNOLOGIES INCHELD+01.64M$469,610$607,114

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2023

6 positions (from 7 filing rows — )
#IssuerClass% PortfolioValueShares
1LANZATECH GLOBAL INCCOM · *W EXP 01/01/20288.69%$21M4.91M
2SATIXFY COMMUNICATIONS LTDORD SHS4.98%$1M2.84M
3RUBICON TECHNOLOGIES INCCL A COM2.54%$607,1141.64M
4SHF HOLDINGS INCCLASS A COM2.15%$514,738971.2K
5OCEAOCEAN BIOMEDICAL INChistory →COM1.62%$386,17964.3K
6SFRTAPPRECIATE HOLDINGS INCCLASS A COM0.02%$3,60210.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2023$18M8Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$24M7Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$34M9May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$58M8Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$58M28Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$101M71Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$14M79May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$151M109Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$238M152Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$157M64Jul 28, 202113F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.